Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Leads from the MMWR

Leads from the MMWR the MMWR Leads from and 34/No. Centers for Disease Atlanta 22, 1985), Mortality Weekly Report (Vol. Control, Morbidity Protection Viral Recommendations for Against Hepatitis The all Immune called immune statement rec¬ following updates previous globulin (IG) (formerly ommendations immune for in the on use of serum or globulins protec¬ ISG, 7-globulin) produced globulin, tion viral contains antibodies the United States against hepatitis (MMWR 1981;30:423-435) against hepati¬ and of B vaccine and B immune A virus the B surface use tis and hepatitis hepatitis (anti-HAV) hepatitis of for B of IG lots since prophylaxis (MMWR antigen (anti-HBs). Tests globulin hepatitis prepared and 1977 indicate that both of have types 1982;31:317-328 1984;33:285-290). antibody been B immune uniformly present. Hepatitis globulin is an IG from Introduction (HBIG) prepared plasma containing used for of anti-HBs. The term "viral is titers commonly high hepatitis" several diseases that are Neither IG nor in the similar HBIG available clinically etiological- commercially distinct.1 Two other viral and of United States transmits or ly epidemiologically these, hepatitis A and infections. There called infectious is no evidence that the causative hepatitis (formerly hepatitis) B called have of serum AIDS virus hepatitis (formerly hepatitis) agents (human T-lymphotropic type been as http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Leads from the MMWR

JAMA , Volume 254 (1) – Jul 5, 1985

Loading next page...
 
/lp/american-medical-association/leads-from-the-mmwr-SdPHrhZ9Zr

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1985 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1985.03360010035005
Publisher site
See Article on Publisher Site

Abstract

the MMWR Leads from and 34/No. Centers for Disease Atlanta 22, 1985), Mortality Weekly Report (Vol. Control, Morbidity Protection Viral Recommendations for Against Hepatitis The all Immune called immune statement rec¬ following updates previous globulin (IG) (formerly ommendations immune for in the on use of serum or globulins protec¬ ISG, 7-globulin) produced globulin, tion viral contains antibodies the United States against hepatitis (MMWR 1981;30:423-435) against hepati¬ and of B vaccine and B immune A virus the B surface use tis and hepatitis hepatitis (anti-HAV) hepatitis of for B of IG lots since prophylaxis (MMWR antigen (anti-HBs). Tests globulin hepatitis prepared and 1977 indicate that both of have types 1982;31:317-328 1984;33:285-290). antibody been B immune uniformly present. Hepatitis globulin is an IG from Introduction (HBIG) prepared plasma containing used for of anti-HBs. The term "viral is titers commonly high hepatitis" several diseases that are Neither IG nor in the similar HBIG available clinically etiological- commercially distinct.1 Two other viral and of United States transmits or ly epidemiologically these, hepatitis A and infections. There called infectious is no evidence that the causative hepatitis (formerly hepatitis) B called have of serum AIDS virus hepatitis (formerly hepatitis) agents (human T-lymphotropic type been as

Journal

JAMAAmerican Medical Association

Published: Jul 5, 1985

There are no references for this article.